IMF Videos Search Content For Care Partner (51) Patient (49) Healthcare Professional (37) Healthcare Provider (37) Series - Any - ASCO/EHA (16) ASH (10) Ask Dr. Durie (19) Black Swan Research Initiative (3) Community Workshops (3) Emerging Therapies (4) Facebook Live (2) Health Equity (3) IMWG (1) Living Well with Myeloma (3) Myeloma in a Minute (4) Myeloma Made Simple (3) Myeloma University (4) Patient & Family Webinar (1) Q&A (3) Recent News and Developments (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (19) High-Risk Myeloma (24) High-risk Smoldering Myeloma (12) Late Relapse (4–6 Lines of Therapy) (15) MGUS (14) Newly Diagnosed (Pre-Treatment or First Treatment) (69) Smoldering Myeloma (23) Types of Therapy Immunomodulatory drugs (IMiDs) (37) Immunotherapies (CAR T; BiTE, etc.) (22) Monoclonal antibodies (27) Proteasome inhibitors (31) Stem cell transplant (38) Steroids (28) Supportive Care (17) Year Published 2026 (6) 2025 (16) 2024 (19) 2023 (13) 2022 (3) 2021 (4) 2019 (5) 2018 (2) 2017 (4) 2016 (5) 2015 (4) Trusted Voices Dr. Brian GM Durie (20) Dr. Joseph Mikhael (20) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (6) Dr. Shaji Kumar (2) Donna Catamero, ANP-BC, OCN, CCRC (1) Dr. María-Victoria Mateos (1) Dr. Saad Usmani (1) Dr. Sigurður Kristinsson (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance M-Power Charlotte Community Workshop March 20, 2021 Health Equity Should I have an autologous stem cell transplant (ASCT)? December 19, 2019 Ask Dr. Durie Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed April 25, 2019 Living Well with Myeloma Why is 17p deletion (17p-) considered to be a poor prognostic factor for myeloma patients? April 4, 2019 Ask Dr. Durie Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65? February 14, 2019 Ask Dr. Durie Two-Year Follow-Up of the IMF's iStopMM (Iceland Screens Treats or Prevents Myeloma) February 6, 2019 Black Swan Research Initiative What are the immediate and long-term side effects of an autologous stem cell transplant (ASCT)? July 19, 2018 Ask Dr. Durie What should patients do if their doctor is unsure if they have smoldering or active myeloma? March 1, 2018 Ask Dr. Durie How to Talk with your Healthcare Team about What’s Best for You October 4, 2017 Living Well with Myeloma Can myeloma cells contaminate a patient’s stem cells that are harvested for transplant? August 31, 2017 Ask Dr. Durie If frontline therapies do not produce a full response, will ASCT do so? March 30, 2017 Ask Dr. Durie Watch CNN Interview Highlighting IMF-Funded Myeloma Research Project in Iceland March 22, 2017 Black Swan Research Initiative Load More
